Welcome to our dedicated page for Balchem news (Ticker: BCPC), a resource for investors and traders seeking the latest updates and insights on Balchem stock.
Balchem Corporation (NASDAQ: BCPC) is a global specialty ingredient manufacturer for health and nutrition markets, and its news flow reflects this focus. Company press releases highlight the development, manufacture and marketing of specialty ingredients that improve and enhance the health and well-being of life on the planet, as well as financial and corporate updates relevant to investors and industry observers.
Visitors to this BCPC news page can review Balchem’s announcements on quarterly financial results, dividend declarations and participation in investor conferences. Recent releases have reported segment-level performance for its Human Nutrition & Health, Animal Nutrition & Health and Specialty Products segments, along with measures such as net sales, earnings from operations, adjusted EBITDA and free cash flow, as described in accompanying Form 8-K filings.
Balchem also issues news related to regulatory and trade developments that affect its markets. For example, the company joined another EU producer in welcoming European Union anti-dumping duties on choline chloride imports from China, emphasizing the importance of fair trade for the EU food and feed supply chain and for maintaining a healthy domestic choline chloride industry.
In addition, Balchem regularly announces its participation in conferences hosted by firms such as CJS Securities, Baird, H.C. Wainwright, Wells Fargo and others, where its leadership presents to the investment community. These updates provide insight into how the company communicates its strategy and segment performance to shareholders and analysts. Investors and researchers can use this news stream to follow Balchem’s financial reporting, capital allocation decisions such as dividends, and its commentary on market and regulatory conditions affecting its human nutrition, animal nutrition and specialty products businesses.
Balchem Corporation will present at Baird’s 2020 Global Industrial Conference on November 12, 2020. The presentation, featuring CEO Ted Harris and CFO Martin Bengtsson, is scheduled for 12:50 p.m. EST. Attendees can access presentation materials in advance via the official website.
Balchem Corporation (NASDAQ: BCPC) reported record third quarter net earnings of $21.6 million for 2020, marking a 4.3% increase from 2019. Net sales rose by 10.4% to $175.1 million, driven by growth in Human and Animal Nutrition sectors. Adjusted net earnings reached $26.9 million, up 2.3% year-over-year, with adjusted EBITDA at $44.4 million, a 10.1% increase. Cash flows from operations were $35.4 million and free cash flow was $28.3 million. The company's net debt decreased to $114.6 million. Balchem continues to implement its ERP system and advances its ESG commitments.
Balchem Corporation (NASDAQ: BCPC) announced a conference call scheduled for October 28, 2020, at 11:00 AM ET to discuss its third-quarter results, which will be published before market opening on the same day. The call will be hosted by CEO Ted Harris and CFO Martin Bengtsson, with a replay available until November 11, 2020. The company, known for enhancing health through its specialty ingredients across various sectors, operates in three segments: Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products.
Balchem Corporation (NASDAQ: BCPC) will present at Morningstar's Management Behind the Moat Conference on September 29, 2020, at 9:00 a.m. EDT. CEO Ted Harris and CFO Martin Bengtsson will lead the presentation. Interested parties can access the presentation materials prior to the event at here.
Balchem focuses on specialty ingredients within three segments: Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products.
Balchem Corporation (NASDAQ: BCPC) will present at the Sidoti Fall 2020 Virtual Investor Conference on September 23, 2020, starting at 2:30 p.m. EDT. The presentation will be led by CEO Ted Harris and CFO Martin Bengtsson. Investors can access a live webcast of the event through a specified link, with a replay available approximately 24 hours later until December 23, 2020.
Balchem specializes in developing and marketing ingredients for health and well-being across various industries, with segments in Human Nutrition, Animal Nutrition, and Specialty Products.
Balchem Corporation (NASDAQ: BCPC) reported a record net earnings of $21.1 million for Q2 2020, reflecting an increase from $19.8 million in Q2 2019. Adjusted net earnings rose to $27.6 million, up 9.2% year-over-year. Net sales reached $173.4 million, a 7.3% increase compared to the previous year. The company's adjusted EBITDA also hit a record $43.9 million, marking a 9.8% growth. Strong cash flow allowed for $35.0 million in debt repayment, reducing net debt to $142.2 million.
Summary not available.
Summary not available.